AKU - Earnings announcements

/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/  PLANTATION, Fla., Jan. 31, 2024 /CNW/ - Akumin Inc. (together with its subsidiaries, "we", "us", "our," "Akumin" or the "Company") (TSX:AKU) (OTC Pink Open Market: AKUMQ) announced today that its previously announced restructuring transaction involving Stonepeak as well as its bondholders, lenders, shareholders and other stakeholders under a prepackaged chapter 11 plan of reorganization (the "Prepackaged Plan") is expected to become effective on or around February 6, 2024 (the "Effective Date"), subject to satisfaction of all of the remaining conditions to the closing of the restructuring transaction. On

PLANTATION, Fla., Aug. 9, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter ended June 30, 2023. Second Quarter 2023 Highlights Akumin delivered second quarter same-store volume performance on a consolidated basis as follows:+3.1% for MRI+16.5% for PET/CT+3.4% for Oncology Patient StartsThe Company reported revenue totaling $184.8 million for the second quarter, a $7.3 million or 4% decrease over the second quarter of last year.

PLANTATION, Fla., Aug. 8, 2023 /PRNewswire/ - Akumin Inc. (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, Thursday, August 10, 2023, to discuss its second quarter 2023 financial results.  The financial results are expected to be available on Wednesday, August 9, 2023. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/Q2-2023-Results-Dial-In-Numbers or via webcast at https://akum.in/Q2-2023-Results-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call

PLANTATION, Fla., May 10, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter ended March 31, 2023. First Quarter 2023 Highlights Akumin delivered first quarter same-store volume performance on a consolidated basis as follows:+4.0% for MRI+16.1% for PET/CT+7.6% for Oncology Patient StartsThe Company reported revenue totaling $187.6 million for the first quarter, a $1.3 million or 1% increase over the first quarter of last year.Net

PLANTATION, Fla., May 4, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, May 11, 2023, to discuss its first quarter 2023 financial results.  The financial results are expected to be available on Wednesday, May 10, 2023. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/Q1-2023-Results-Dial-In-Numbers or via webcast at https://akum.in/Q1-2023-Results-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call to

PLANTATION, Fla., March 16, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter and year ended December 31, 2022. Fourth Quarter 2022 Highlights Akumin delivered fourth quarter same-store volume performance on a consolidated, pro forma basis as follows:-0.3% for MRI+7.8% for PET/CT+8.0% for Oncology Patient StartsThe Company reported revenue totaling $184.6 million for the fourth quarter, a $5.2 million or 3% increase over the fou

PLANTATION, Fla., March 10, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, March 17, 2023, to discuss its year-end 2022 financial results.  The financial results are expected to be available on Thursday, March 16, 2023. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/2022-YearEndResults-Audio or via webcast at https://akum.in/2022-YearEndResults-Webcast. A related presentation will be available from Akumin's website (www.akumin.com).  Participants are asked to connect at least 10 minutes prior to the beginning of the call to

PLANTATION, Fla., Nov. 9, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter ended September 30, 2022. Third Quarter 2022 Highlights Akumin's radiology business delivered third quarter same-store volume performance on a consolidated, pro forma basis assuming the Company's acquisition of Alliance HealthCare Services was completed as of January 1, 2021:+0.2% for MRI+7.8% for PET/CT(2.5%) for Total Radiology Procedures(0.2%) for Onco

PLANTATION, Fla., Nov. 3, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, November 10, 2022, to discuss its third quarter 2022 financial results.  The financial results are expected to be available on Wednesday, November 9, 2022. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/Q3-2022-Results-Audio or via webcast at https://akum.in/Q3-2022-Results-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call to

PLANTATION, Fla., Aug. 9, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups with comprehensive solutions addressing outsourced radiology and oncology service line needs, announced today its financial results for the quarter ended June 30, 2022. Second Quarter 2022 Highlights Akumin's radiology business delivered strong quarterly same store volume performance on a consolidated pro forma basis, which assumes the Company's acquisition of Alliance HealthCare Services, Inc. ("Alliance") was completed as of January 1, 2021:+2.0% for MRI+6.4% for PET/CT+4.5% for Total Radiology Pro

PLANTATION, Fla., Aug. 4, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, August 10, 2022, to discuss its second quarter 2022 financial results.  The financial results are expected to be available on Tuesday, August 9, 2022. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/Q2-2022-Results-Audio or via webcast at https://akum.in/Q2-2022-Results-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call to ensur

PLANTATION, Fla., May 10, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national leader in comprehensive outpatient radiology and oncology solutions and a partner of choice for U.S. hospitals, health systems and physician groups, announced today its financial results for the quarter ended March 31, 2022. First Quarter 2022 Highlights Revenue totaling $186.3 million for the first quarter, a $122.3 million or 191.2% increase from $64.0 million in the first quarter of last year. The increase is significantly attributable to the Company's acquisition of Alliance HealthCare Services on September 1, 2021.  Revenue increased $6.8 million or 3.8% over the four

PLANTATION, Fla., May 5, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, May 11, 2022, to discuss its first quarter 2022 financial results. The financial results are expected to be available on Tuesday, May 10, 2022. To access the conference call, participants may join by registering for the conference at https://akum.in/Q1-2022-Results-Audio or via webcast at https://akum.in/Q1-2022-Results-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call to ensure participation. The webcast

PLANTATION, Fla., March 16, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service line needs, announced today its financial results for the quarter and year ended December 31, 2021. Fourth Quarter 2021 Highlights Akumin delivered strong quarterly same store volume performance on a consolidated, pro forma basis: +6.2% for MRI +4.2% for PET/CT +3.0% for Total Radiology Procedures +4.5% for Oncology Patient StartsThe Company reported revenue totaling $179.4 million for the fourth quarter, a $112.6 mi

PLANTATION, Fla., March 14, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:00 a.m. Eastern Time, March 17, 2022, to discuss its year-end 2021 financial results.  The financial results are expected to be available on Wednesday, March 16, 2022. To access the conference call, dial toll-free in the U.S. or Canada 888-256-1007 or, for international callers, 647-484-0478.  A related presentation will be available from Akumin's public disclosure at www.sedar.com or www.sec.gov and also from Akumin's website (www.akumin.com) and at https://akum.in/2021-ResultsCall.  Participants are asked to connect at least 10 minutes prior to the

PLANTATION, FL, Dec 15, 2021 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") is pleased to announce today its full-year 2022 financial guidance, following the previously announced closing of the Alliance Healthcare Services, Inc. ("Alliance") acquisition.  The Alliance acquisition closed on September 1, 2021, and Consolidated Financial Results for the quarter ended September 30th, 2021, which includes only one month of Alliance results, were released on December 13th, 2021. Akumin currently expects that the financial results of the combined company for 2022 will be as follows: Summary Consolidated Financial Results (in thousands, except for per share amounts) Ak

PLANTATION, Fla., Dec. 13, 2021 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") announced today its financial results for the quarter ended September 30, 2021 ("Q3 Fiscal 2021"). Third Quarter 2021 Highlights Akumin completed its acquisition of Alliance HealthCare Services, Inc. ("Alliance") on September 1, 2021, transforming Akumin to the hospital partner of choice in both Radiology and Oncology solutions. The Company operations now span 46 states, serving ~1,000 hospital and healthcare providers, operating over 230 radiology and oncology fixed site locations, with over 2 million procedures and treatments per year on pro forma basis. Akumin delivered strong qua

PLANTATION, FLA., Dec. 6, 2021 /CNW/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin") is providing this update on the status of the management cease trade order granted by the Ontario Securities Commission (the "OSC"), as principal regulator of Akumin, on August 20, 2021 (the "MCTO") under National Policy 12-203 – Management Cease Trader Orders ("NP 12-203"). The MCTO was granted following Akumin's application to the OSC once it was determined it was not in a position to file its interim financial report for the quarter ended June 30, 2021 along with the related management's discussion and analysis and CEO and CFO certificates (collectively, the "Required Reports") by the reporting deadline o

PLANTATION, Fla., Nov. 22, 2021 /CNW/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin") is providing this update on the status of the management cease trade order granted by the Ontario Securities Commission (the "OSC"), as principal regulator of Akumin, on August 20, 2021 (the "MCTO") under National Policy 12-203 – Management Cease Trader Orders ("NP 12-203"). The MCTO was granted following Akumin's application to the OSC once it was determined it was not in a position to file its interim financial report for the quarter ended June 30, 2021 along with the related management's discussion and analysis and CEO and CFO certificates (collectively, the "Required Reports") by the reporting deadline

PLANTATION, Fla., Nov. 8, 2021 /CNW/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin") is providing this update on the status of the management cease trade order granted by the Ontario Securities Commission (the "OSC"), as principal regulator of Akumin, on August 20, 2021 (the "MCTO") under National Policy 12-203 – Management Cease Trader Orders ("NP 12-203"). The MCTO was granted following Akumin's application to the OSC once it was determined it was not in a position to file its interim financial report for the quarter ended June 30, 2021 along with the related management's discussion and analysis and CEO and CFO certificates (collectively, the "Required Reports") by the reporting deadline o

PLANTATION, Fla., Oct. 25, 2021 /CNW/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin") is providing this update on the status of the management cease trade order granted by the Ontario Securities Commission (the "OSC"), as principal regulator of Akumin, on August 20, 2021 (the "MCTO") under National Policy 12-203 – Management Cease Trader Orders ("NP 12-203"). The MCTO was granted following Akumin's application to the OSC once it was determined it was not in a position to file its interim financial report for the quarter ended June 30, 2021 along with the related management's discussion and analysis and CEO and CFO certificates (collectively, the "Required Reports") by the reporting deadline

PLANTATION, Fla., Aug. 9, 2021 /CNW/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, August 16, 2021, to discuss its second quarter 2021 financial results.  The second quarter 2021 financial results are expected to be available on Monday, August 16, 2021. To access the conference call, dial toll-free in Canada or the U.S. 800-437-2398 or, for international callers, 647-792-1240.  Participants are asked to connect at least 10 minutes prior to the beginning of the call to ensure participation.  There will also be simultaneous and archived webcasts available at https://akum.in/Q22021-ResultsCall. The webcast archive will be